K. Bergstrom

发表

Sunscreen update: the controversies, what's safe, what's next.

K. Bergstrom, 2010, Journal of drugs in dermatology : JDD.

Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.

A. Kimball, Karina Arambula, K. Bergstrom, 2003, Cutis.

Cutaneous Manifestations of Drug Addiction

K. Bergstrom, M. Sánchez, 2010 .

Cutaneous clues to drug addiction.

K. Bergstrom, 2008, Journal of drugs in dermatology : JDD.

Chronic ulcers: when to consider malignancy?

K. Bergstrom, 2012, Journal of drugs in dermatology : JDD.

Hyperpigmentation: old problem, new therapies.

K. Bergstrom, S. K. Que, 2009, Journal of drugs in dermatology : JDD.

Vitiligo: nonsurgical treatment options and the evidence behind their use.

K. Bergstrom, Jeremy S Fenton, 2008, Journal of drugs in dermatology : JDD.

A polyomavirus may cause merkel cell carcinoma: implications for immunosuppressed states and viral reactivation.

K. Bergstrom, 2008, Journal of Drugs in Dermatology.

Skin cancer examination teaching in US medical education.

Donald R. Miller, B. Gilchrest, A. Geller, 2006, Archives of dermatology.

Everything old is new again: spironolactone and metformin in the treatment of acne.

K. Bergstrom, 2010, Journal of drugs in dermatology : JDD.

Extragenital lichen sclerosus et atrophicus.

H. Kamino, K. Bergstrom, D. Ramsay, 2008, Dermatology online journal.

Update on antibacterial soaps: the FDA takes a second look at triclosans.

K. Bergstrom, 2014, Journal of drugs in dermatology : JDD.

What's new in treatment of keloids? New applications for common therapies, new treatments to come.

K. Bergstrom, S. K. Que, 2011, Journal of drugs in dermatology : JDD.